Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge
Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The study will investigate the effect of treatment with RNS60 for 21 days. Subjects' FEV1
will be measured after an inhaled allergen challenge at baseline and again after 21 days of
treatment.